Tissue Services

All recovered tissues are initially placed in quarantine and donor records are reviewed and evaluated. During this time, tests for infectious disease or other transmissible agents are completed. To ensure that the blood sample is adequate for testing, the potential for dilution of the donor’s plasma by administration of large volumes of crystalloid or blood products is evaluated.

Results must be reported as nonreactive in order for a donor’s tissues to be considered safe. Medical Director(s) reviews results and makes the final determination regarding donor suitability. Once the donor has been deemed suitable, tissues are transferred from the quarantine inventory into final processing or directly to distribution.

The recovered tissue process:

Donor is referred, donation is consented, and the donor is screened.

Donor family and additional interviews are conducted.

Recovered tissue is placed in quarantine.

Donor evaluation continues.

Medical records and autopsy reports are ordered and reviewed.

Tests for infectious disease or other transmissible agents are completed. All donors are tested for hepatitis B, hepatitis C, syphilis (RPR), HIV, human T-lymphotropic virus type 1 (HTLV-1).

Once information is obtained and reviewed by the Quality Assessment staff, the Medical Director(s) reviews charts and makes the final determination regarding donor suitability.

If Medical Director deems donor suitable, tissues are transferred from the quarantine inventory into final processing or directly to distribution.